- Report
- August 2024
- 175 Pages
Global
From €4780EUR$5,000USD£4,002GBP
- Report
- April 2025
- 50 Pages
Global
From €2534EUR$2,650USD£2,121GBP
- Report
- January 2025
- 185 Pages
Global
From €4302EUR$4,500USD£3,601GBP
- Report
- February 2022
- 269 Pages
Global
From €9083EUR$9,500USD£7,603GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1434EUR$1,500USD£1,200GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1195EUR$1,250USD£1,000GBP
- Report
- February 2024
- 118 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Report
- August 2022
- 115 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$3,921USD£3,032GBP
- Report
- November 2022
- 175 Pages
Global
From €3442EUR$3,600USD£2,881GBP
- Report
- January 2024
- 113 Pages
United States
€3346EUR$3,500USD£2,801GBP
- Report
- April 2025
- 50 Pages
Global
From €2534EUR$2,650USD£2,121GBP
- Report
- April 2025
- 50 Pages
Global
From €2534EUR$2,650USD£2,121GBP
- Report
- April 2025
- 50 Pages
Global
From €2534EUR$2,650USD£2,121GBP
- Report
- October 2024
- 23 Pages
Cameroon
From €995EUR$1,115USD£862GBP

Hydrocortisone is a glucocorticoid medication used to treat a variety of gastrointestinal conditions, including ulcerative colitis, Crohn's disease, and irritable bowel syndrome. It is used to reduce inflammation and suppress the immune system. It is available in both oral and topical forms. Oral hydrocortisone is typically used to treat more severe cases of gastrointestinal conditions, while topical hydrocortisone is used to treat milder cases.
Hydrocortisone is a widely used medication in the gastrointestinal drugs market. It is often prescribed as a first-line treatment for many gastrointestinal conditions, due to its effectiveness and relatively low cost. It is also used in combination with other medications to treat more severe cases.
Some companies in the hydrocortisone market include Pfizer, Merck, GlaxoSmithKline, and Novartis. Show Less Read more